Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 69 entries
Sorted by: Best Match Show Resources per page
Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis.

Scientific reports

Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER.
PMID: 26373621
Sci Rep. 2015 Sep 16;5:13510. doi: 10.1038/srep13510.

No abstract available.

Cite
Meyer MR, Fredette NC, Howard TA, et al. Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis. Sci Rep. 2015;5:13510doi: 10.1038/srep13510.
Meyer, M. R., Fredette, N. C., Howard, T. A., Hu, C., Ramesh, C., Daniel, C., Amann, K., Arterburn, J. B., Barton, M., & Prossnitz, E. R. (2015). Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis. Scientific reports, 513510. https://doi.org/10.1038/srep13510
Meyer, Matthias R, et al. "Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis." Scientific reports vol. 5 (2015): 13510. doi: https://doi.org/10.1038/srep13510
Meyer MR, Fredette NC, Howard TA, Hu C, Ramesh C, Daniel C, Amann K, Arterburn JB, Barton M, Prossnitz ER. Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis. Sci Rep. 2015 Sep 16;5:13510. doi: 10.1038/srep13510. PMID: 26373621; PMCID: PMC4649992.
Copy Download .nbib Format: NLM
IS SUCCESS IN WEIGHT LOSS TREATMENT CONTAGIOUS (DO ATTENDANCE AND OUTCOMES CLUSTER WITHIN TREATMENT GROUPS)?.

Obesity research & clinical practice

Simon GE, Rohde P, Ludman EJ, Jeffery RW, Linde JA, Operskalski BH, Arterburn D, Finch EA.
PMID: 21057667
Obes Res Clin Pract. 2010 Oct 06;4(4):283-291. doi: 10.1016/j.orcp.2010.09.179.

Data from a trial of a 26-session structured group behavioral weight loss intervention were used to examine how group attendance, weight loss, and changes in depression clustered within therapy groups. Participants were recruited via a population-based survey of female...

Cite
Simon GE, Rohde P, Ludman EJ, et al. IS SUCCESS IN WEIGHT LOSS TREATMENT CONTAGIOUS (DO ATTENDANCE AND OUTCOMES CLUSTER WITHIN TREATMENT GROUPS)?. Obes Res Clin Pract. 2010;4(4):283-291doi: 10.1016/j.orcp.2010.09.179.
Simon, G. E., Rohde, P., Ludman, E. J., Jeffery, R. W., Linde, J. A., Operskalski, B. H., Arterburn, D., & Finch, E. A. (2010). IS SUCCESS IN WEIGHT LOSS TREATMENT CONTAGIOUS (DO ATTENDANCE AND OUTCOMES CLUSTER WITHIN TREATMENT GROUPS)?. Obesity research & clinical practice, 4(4), 283-291. https://doi.org/10.1016/j.orcp.2010.09.179
Simon, Gregory E, et al. "IS SUCCESS IN WEIGHT LOSS TREATMENT CONTAGIOUS (DO ATTENDANCE AND OUTCOMES CLUSTER WITHIN TREATMENT GROUPS)?." Obesity research & clinical practice vol. 4,4 (2010): 283-291. doi: https://doi.org/10.1016/j.orcp.2010.09.179
Simon GE, Rohde P, Ludman EJ, Jeffery RW, Linde JA, Operskalski BH, Arterburn D, Finch EA. IS SUCCESS IN WEIGHT LOSS TREATMENT CONTAGIOUS (DO ATTENDANCE AND OUTCOMES CLUSTER WITHIN TREATMENT GROUPS)?. Obes Res Clin Pract. 2010 Oct 06;4(4):283-291. doi: 10.1016/j.orcp.2010.09.179. PMID: 21057667; PMCID: PMC2971553.
Copy Download .nbib Format: NLM
Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults.

Contemporary clinical trials

Rosenberg DE, Greenwood-Hickman MA, Zhou J, Cook AJ, Mettert KD, Cooper J, Arterburn D, Green BB, Walsh-Bailey C, Kerr J, Owen N, Dunstan D, McClure JB.
PMID: 34666182
Contemp Clin Trials. 2021 Dec;111:106593. doi: 10.1016/j.cct.2021.106593. Epub 2021 Oct 16.

Older adults with obesity spend the majority of their waking hours sedentary. Given substantial barriers to regular physical activity in this population, approaches to reduce sedentary time could be an effective health promotion strategy. We present the protocol of...

Cite
Rosenberg DE, Greenwood-Hickman MA, Zhou J, et al. Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemp Clin Trials. 2021;111:106593doi: 10.1016/j.cct.2021.106593.
Rosenberg, D. E., Greenwood-Hickman, M. A., Zhou, J., Cook, A. J., Mettert, K. D., Cooper, J., Arterburn, D., Green, B. B., Walsh-Bailey, C., Kerr, J., Owen, N., Dunstan, D., & McClure, J. B. (2021). Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemporary clinical trials, 111106593. https://doi.org/10.1016/j.cct.2021.106593
Rosenberg, Dori E, et al. "Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults." Contemporary clinical trials vol. 111 (2021): 106593. doi: https://doi.org/10.1016/j.cct.2021.106593
Rosenberg DE, Greenwood-Hickman MA, Zhou J, Cook AJ, Mettert KD, Cooper J, Arterburn D, Green BB, Walsh-Bailey C, Kerr J, Owen N, Dunstan D, McClure JB. Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemp Clin Trials. 2021 Dec;111:106593. doi: 10.1016/j.cct.2021.106593. Epub 2021 Oct 16. PMID: 34666182.
Copy Download .nbib Format: NLM
Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity.

JAMA surgery

Howard R, Chao GF, Yang J, Thumma J, Chhabra K, Arterburn DE, Ryan A, Telem DA, Dimick JB.
PMID: 34613354
JAMA Surg. 2021 Dec 01;156(12):1160-1169. doi: 10.1001/jamasurg.2021.4981.

IMPORTANCE: Sleeve gastrectomy is the most widely used bariatric operation; however, its long-term safety is largely unknown.OBJECTIVE: To compare the risk of mortality, complications, reintervention, and health care use 5 years after sleeve gastrectomy and gastric bypass.DESIGN, SETTING, AND...

Cite
Howard R, Chao GF, Yang J, et al. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surg. 2021;156(12):1160-1169doi: 10.1001/jamasurg.2021.4981.
Howard, R., Chao, G. F., Yang, J., Thumma, J., Chhabra, K., Arterburn, D. E., Ryan, A., Telem, D. A., & Dimick, J. B. (2021). Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA surgery, 156(12), 1160-1169. https://doi.org/10.1001/jamasurg.2021.4981
Howard, Ryan, et al. "Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity." JAMA surgery vol. 156,12 (2021): 1160-1169. doi: https://doi.org/10.1001/jamasurg.2021.4981
Howard R, Chao GF, Yang J, Thumma J, Chhabra K, Arterburn DE, Ryan A, Telem DA, Dimick JB. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surg. 2021 Dec 01;156(12):1160-1169. doi: 10.1001/jamasurg.2021.4981. PMID: 34613354; PMCID: PMC8495604.
Copy Download .nbib Format: NLM
Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults.

Contemporary clinical trials

Rosenberg DE, Greenwood-Hickman MA, Zhou J, Cook AJ, Mettert KD, Cooper J, Arterburn D, Green BB, Walsh-Bailey C, Kerr J, Owen N, Dunstan D, McClure JB.
PMID: 34666182
Contemp Clin Trials. 2021 Dec;111:106593. doi: 10.1016/j.cct.2021.106593. Epub 2021 Oct 16.

Older adults with obesity spend the majority of their waking hours sedentary. Given substantial barriers to regular physical activity in this population, approaches to reduce sedentary time could be an effective health promotion strategy. We present the protocol of...

Cite
Rosenberg DE, Greenwood-Hickman MA, Zhou J, et al. Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemp Clin Trials. 2021;111:106593doi: 10.1016/j.cct.2021.106593.
Rosenberg, D. E., Greenwood-Hickman, M. A., Zhou, J., Cook, A. J., Mettert, K. D., Cooper, J., Arterburn, D., Green, B. B., Walsh-Bailey, C., Kerr, J., Owen, N., Dunstan, D., & McClure, J. B. (2021). Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemporary clinical trials, 111106593. https://doi.org/10.1016/j.cct.2021.106593
Rosenberg, Dori E, et al. "Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults." Contemporary clinical trials vol. 111 (2021): 106593. doi: https://doi.org/10.1016/j.cct.2021.106593
Rosenberg DE, Greenwood-Hickman MA, Zhou J, Cook AJ, Mettert KD, Cooper J, Arterburn D, Green BB, Walsh-Bailey C, Kerr J, Owen N, Dunstan D, McClure JB. Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults. Contemp Clin Trials. 2021 Dec;111:106593. doi: 10.1016/j.cct.2021.106593. Epub 2021 Oct 16. PMID: 34666182.
Copy Download .nbib Format: NLM
Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.

JAMA

Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE.
PMID: 31475297
JAMA. 2019 Oct 01;322(13):1271-1282. doi: 10.1001/jama.2019.14231.

IMPORTANCE: Although metabolic surgery (defined as procedures that influence metabolism by inducing weight loss and altering gastrointestinal physiology) significantly improves cardiometabolic risk factors, the effect on cardiovascular outcomes has been less well characterized.OBJECTIVE: To investigate the relationship between metabolic...

Cite
Aminian A, Zajichek A, Arterburn DE, et al. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019;322(13):1271-1282doi: 10.1001/jama.2019.14231.
Aminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E. (2019). Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA, 322(13), 1271-1282. https://doi.org/10.1001/jama.2019.14231
Aminian, Ali, et al. "Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity." JAMA vol. 322,13 (2019): 1271-1282. doi: https://doi.org/10.1001/jama.2019.14231
Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019 Oct 01;322(13):1271-1282. doi: 10.1001/jama.2019.14231. PMID: 31475297; PMCID: PMC6724187.
Copy Download .nbib Format: NLM
Behavioural and psychosocial factors associated with 5-year weight trajectories within the PORTAL Overweight/Obesity Cohort.

Obesity science & practice

Fitzpatrick SL, Rosales AG, Brown SD, Arterburn DE, Daley MF, Horberg M, Koebnick C, Oshiro C, Young DR.
PMID: 32523716
Obes Sci Pract. 2020 Feb 27;6(3):272-281. doi: 10.1002/osp4.411. eCollection 2020 Jun.

OBJECTIVE: The purpose of this study was to model weight trajectories over a 5-year time period (2012-2016) and their association with behavioural and psychosocial characteristics and health care-related experiences using data from the Patient Outcomes Research to Advance Learning...

Cite
Fitzpatrick SL, Rosales AG, Brown SD, et al. Behavioural and psychosocial factors associated with 5-year weight trajectories within the PORTAL Overweight/Obesity Cohort. Obes Sci Pract. 2020;6(3):272-281doi: 10.1002/osp4.411.
Fitzpatrick, S. L., Rosales, A. G., Brown, S. D., Arterburn, D. E., Daley, M. F., Horberg, M., Koebnick, C., Oshiro, C., & Young, D. R. (2020). Behavioural and psychosocial factors associated with 5-year weight trajectories within the PORTAL Overweight/Obesity Cohort. Obesity science & practice, 6(3), 272-281. https://doi.org/10.1002/osp4.411
Fitzpatrick, Stephanie L, et al. "Behavioural and psychosocial factors associated with 5-year weight trajectories within the PORTAL Overweight/Obesity Cohort." Obesity science & practice vol. 6,3 (2020): 272-281. doi: https://doi.org/10.1002/osp4.411
Fitzpatrick SL, Rosales AG, Brown SD, Arterburn DE, Daley MF, Horberg M, Koebnick C, Oshiro C, Young DR. Behavioural and psychosocial factors associated with 5-year weight trajectories within the PORTAL Overweight/Obesity Cohort. Obes Sci Pract. 2020 Feb 27;6(3):272-281. doi: 10.1002/osp4.411. eCollection 2020 Jun. PMID: 32523716; PMCID: PMC7278910.
Copy Download .nbib Format: NLM
From the clinic to the community: Can health system data accurately estimate population obesity prevalence?.

Obesity (Silver Spring, Md.)

Mooney SJ, Song L, Drewnowski A, Buskiewicz J, Mooney SD, Saelens BE, Arterburn DE.
PMID: 34605194
Obesity (Silver Spring). 2021 Nov;29(11):1961-1968. doi: 10.1002/oby.23273. Epub 2021 Oct 04.

OBJECTIVE: Health system data were assessed for how well they can estimate obesity prevalence in census tracts.METHODS: Clinical visit data were available from two large health systems (Kaiser Permanente Washington and University of Washington Medicine) in King County, Washington,...

Cite
Mooney SJ, Song L, Drewnowski A, et al. From the clinic to the community: Can health system data accurately estimate population obesity prevalence?. Obesity (Silver Spring). 2021;29(11):1961-1968doi: 10.1002/oby.23273.
Mooney, S. J., Song, L., Drewnowski, A., Buskiewicz, J., Mooney, S. D., Saelens, B. E., & Arterburn, D. E. (2021). From the clinic to the community: Can health system data accurately estimate population obesity prevalence?. Obesity (Silver Spring, Md.), 29(11), 1961-1968. https://doi.org/10.1002/oby.23273
Mooney, Stephen J, et al. "From the clinic to the community: Can health system data accurately estimate population obesity prevalence?." Obesity (Silver Spring, Md.) vol. 29,11 (2021): 1961-1968. doi: https://doi.org/10.1002/oby.23273
Mooney SJ, Song L, Drewnowski A, Buskiewicz J, Mooney SD, Saelens BE, Arterburn DE. From the clinic to the community: Can health system data accurately estimate population obesity prevalence?. Obesity (Silver Spring). 2021 Nov;29(11):1961-1968. doi: 10.1002/oby.23273. Epub 2021 Oct 04. PMID: 34605194; PMCID: PMC8571026.
Copy Download .nbib Format: NLM
Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.

JAMA network open

Arterburn D, Lewis KH.
PMID: 34499140
JAMA Netw Open. 2021 Sep 01;4(9):e2122541. doi: 10.1001/jamanetworkopen.2021.22541.

No abstract available.

Cite
Arterburn D, Lewis KH. Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. JAMA Netw Open. 2021;4(9):e2122541doi: 10.1001/jamanetworkopen.2021.22541.
Arterburn, D., & Lewis, K. H. (2021). Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. JAMA network open, 4(9), e2122541. https://doi.org/10.1001/jamanetworkopen.2021.22541
Arterburn, David, and Lewis, Kristina H. "Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass." JAMA network open vol. 4,9 (2021): e2122541. doi: https://doi.org/10.1001/jamanetworkopen.2021.22541
Arterburn D, Lewis KH. Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. JAMA Netw Open. 2021 Sep 01;4(9):e2122541. doi: 10.1001/jamanetworkopen.2021.22541. PMID: 34499140.
Copy Download .nbib Format: NLM
Does the built environment have independent obesogenic power? Urban form and trajectories of weight gain.

International journal of obesity (2005)

Buszkiewicz JH, Bobb JF, Hurvitz PM, Arterburn D, Moudon AV, Cook A, Mooney SJ, Cruz M, Gupta S, Lozano P, Rosenberg DE, Theis MK, Anau J, Drewnowski A.
PMID: 33976378
Int J Obes (Lond). 2021 Sep;45(9):1914-1924. doi: 10.1038/s41366-021-00836-z. Epub 2021 May 11.

OBJECTIVE: To determine whether selected features of the built environment can predict weight gain in a large longitudinal cohort of adults.METHODS: Weight trajectories over a 5-year period were obtained from electronic health records for 115,260 insured patients aged 18-64...

Cite
Buszkiewicz JH, Bobb JF, Hurvitz PM, et al. Does the built environment have independent obesogenic power? Urban form and trajectories of weight gain. Int J Obes (Lond). 2021;45(9):1914-1924doi: 10.1038/s41366-021-00836-z.
Buszkiewicz, J. H., Bobb, J. F., Hurvitz, P. M., Arterburn, D., Moudon, A. V., Cook, A., Mooney, S. J., Cruz, M., Gupta, S., Lozano, P., Rosenberg, D. E., Theis, M. K., Anau, J., & Drewnowski, A. (2021). Does the built environment have independent obesogenic power? Urban form and trajectories of weight gain. International journal of obesity (2005), 45(9), 1914-1924. https://doi.org/10.1038/s41366-021-00836-z
Buszkiewicz, James H, et al. "Does the built environment have independent obesogenic power? Urban form and trajectories of weight gain." International journal of obesity (2005) vol. 45,9 (2021): 1914-1924. doi: https://doi.org/10.1038/s41366-021-00836-z
Buszkiewicz JH, Bobb JF, Hurvitz PM, Arterburn D, Moudon AV, Cook A, Mooney SJ, Cruz M, Gupta S, Lozano P, Rosenberg DE, Theis MK, Anau J, Drewnowski A. Does the built environment have independent obesogenic power? Urban form and trajectories of weight gain. Int J Obes (Lond). 2021 Sep;45(9):1914-1924. doi: 10.1038/s41366-021-00836-z. Epub 2021 May 11. PMID: 33976378; PMCID: PMC8592117.
Copy Download .nbib Format: NLM
Solid-Supported Hydrazine Substrate For Labeling Estradiol Ligands with Rhenium.

Angewandte Chemie (International ed. in English)

Arterburn JB, Rao KV, Perry MC.
PMID: 10760864
Angew Chem Int Ed Engl. 2000 Feb;39(4):771-772.

No abstract available.

Cite
Arterburn JB, Rao KV, Perry MC. Solid-Supported Hydrazine Substrate For Labeling Estradiol Ligands with Rhenium. Angew Chem Int Ed Engl. 2000;39(4):771-772
Arterburn, J. B., Rao, K. V., & Perry, M. C. (2000). Solid-Supported Hydrazine Substrate For Labeling Estradiol Ligands with Rhenium. Angewandte Chemie (International ed. in English), 39(4), 771-772.
Arterburn, et al. "Solid-Supported Hydrazine Substrate For Labeling Estradiol Ligands with Rhenium." Angewandte Chemie (International ed. in English) vol. 39,4 (2000): 771-772.
Arterburn JB, Rao KV, Perry MC. Solid-Supported Hydrazine Substrate For Labeling Estradiol Ligands with Rhenium. Angew Chem Int Ed Engl. 2000 Feb;39(4):771-772. PMID: 10760864.
Copy Download .nbib Format: NLM
Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity.

Obesity science & practice

Arterburn LM, Coleman CD, Kiel J, Kelley K, Mantilla L, Frye N, Sanoshy K, Cook CM.
PMID: 30820327
Obes Sci Pract. 2018 Dec 21;5(1):3-14. doi: 10.1002/osp4.312. eCollection 2019 Feb.

OBJECTIVE: Lifestyle interventions remain the cornerstone for obesity treatment. Commercial programs offer one weight loss approach, yet the efficacy of few such programs have been rigorously investigated. The purpose of this study was to evaluate the efficacy of two...

Cite
Arterburn LM, Coleman CD, Kiel J, et al. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. 2018;5(1):3-14doi: 10.1002/osp4.312.
Arterburn, L. M., Coleman, C. D., Kiel, J., Kelley, K., Mantilla, L., Frye, N., Sanoshy, K., & Cook, C. M. (2019). Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obesity science & practice, 5(1), 3-14. https://doi.org/10.1002/osp4.312
Arterburn, L M, et al. "Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity." Obesity science & practice vol. 5,1 (2019): 3-14. doi: https://doi.org/10.1002/osp4.312
Arterburn LM, Coleman CD, Kiel J, Kelley K, Mantilla L, Frye N, Sanoshy K, Cook CM. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. 2018 Dec 21;5(1):3-14. doi: 10.1002/osp4.312. eCollection 2019 Feb. PMID: 30820327; PMCID: PMC6381299.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 69 entries